GlassScriptPhysician profile
Katelyn Ellen Stechschulte
NPI 1508321431
$1,580.58
in general payments reported to CMS, 2019-2025
17 companies · $40.45 in 2025
The $40.45 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,096 · 2022: $363 · 2023: $14.31 · 2024: $66.11 · 2025: $40.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $265.50 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $224.16 | 2021-2022 | |
| Abbvie INC. | $173.37 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $129.02 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $128.88 | 2021 | |
| Medtronic, INC. | $111.97 | 2021-2022 | |
| Boston Scientific Corporation | $97.45 | 2021 | |
| Vertos Medical, INC. | $91.05 | 2021-2023 | Mild Device Kit |
| Depuy Synthes Sales INC. | $85.04 | 2024-2025 | Orthovisc, Monovisc |
| Nalu Medical, INC. | $60.80 | 2021 | |
| Stimwave Technologies Incorporated | $56.79 | 2021 | |
| Grt US Holding, INC. | $43.79 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $33.71 | 2022 | |
| Amgen INC. | $26.65 | 2021 | |
| Lilly USA, LLC | $25.37 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.03 | 2021 | |
| Mdd US Operations, LLC | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Stechschulte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.